|
Dec 01, 2023
|
AC Immune Strengthens Management, Appoints Madiha Derouazi as CSO and Christopher Roberts as CFO
|
|
|
Nov 07, 2023
|
AC Immune to Present at the Jefferies 2023 London Healthcare Conference
|
|
|
Nov 03, 2023
|
AC Immune Reports Third Quarter 2023 Financial Results and Provides a Corporate Update
|
|
|
Nov 02, 2023
|
AC Immune to Host KOL Webinar on Amyloid Plaque PET Imaging in Alzheimer’s Disease as a Surrogate of Clinical Efficacy on November 9, 2023
|
|
|
Oct 27, 2023
|
AC Immune Clinical Data Published in Nature Communications Show Alpha-Synuclein PET Tracer ACI-12589 Has Potential as Neurodegenerative Disease Diagnostic
|
|
|
Oct 17, 2023
|
AC Immune Announces Upcoming Presentations at the 16th CTAD Conference
|
|
|
Oct 05, 2023
|
AC Immune to Present at the Jefferies 2023 CNS & Neuro Summit in October 2023
|
|
|
Sep 05, 2023
|
AC Immune to Present at the H.C. Wainwright 25th Annual Global Investment Conference in September 2023
|
|
|
Aug 04, 2023
|
AC Immune Reports Second Quarter 2023 Financial Results and Provides a Corporate Update
|
|
|
Jul 28, 2023
|
AC Immune to Present at the BTIG Virtual Biotechnology Conference 2023
|
|